Meet the Team
HNL Lab Medicine is a team of highly dedicated medical professionals, scientists and experts who share the vision of creating a healthier and better-informed world. We are committed to those patients and healthcare professionals we serve and strive to provide unparalleled technical expertise and service.
Our Leadership
With experts in pathology, patient service and clinical operations, our leadership team sets our collective course toward creating better care, better outcomes and better futures through lab medicine.
Our Pathologists
With experts in pathology, patient service and clinical operations, our leadership team sets our collective course toward creating better care, better outcomes and better futures through lab medicine.
Our Board Members
With experts in pathology, patient service and clinical operations, our leadership team sets our collective course toward creating better care, better outcomes and better futures through lab medicine.
Martin K. Till
President and Chief Executive Officer (CEO)
Martin Till serves as our President and Chief Executive Officer (CEO) of HNL Lab Medicine (HNL).
Previously, Martin held the position of CEO of Adept Group, the leading packaging consultancy in the United States. He served as President and remains a shareholder of Virtual Graphics, LLC, a leading technology company in the direct thermal material business, and was the Regional President of J.G. Petrucci Company, Inc., a real estate development and design/build company in the region.
From 1998-2012, Mr. Till was Chief Executive Officer, President and Publisher of The Express-Times and lehighvalleylive.com. Also serving as President of Penn Jersey Advance, the parent company to The Express-Times from 2004-2012, overseeing six daily newspapers, 26 weekly publications and regional websites throughout eastern Pennsylvania and New Jersey.
He earned a bachelor’s degree in business administration from North American University. Mr. Till was a non-commissioned officer in the U.S. Army.
In 2005, Mr. Till was a founding Board member of Team Capital Bank (now Provident Bank).
He serves on the boards for:
Lehigh Valley Health Network (co-Chair)
Health Network Laboratories (Chair)
The Lehigh Valley Partnership
Mr. Till previously served on the Boards of Lafayette Ambassador Bank (Fulton Bank), The Pennsylvania Society, United Way of the Lehigh Valley, and the Pennsylvania News Media Association.
Mr. Till lives in Coopersburg with his wife, Tiffany, and has two children.
Warren W Erdmann
Chief Operating Officer (COO)
Warren Erdmann serves as Chief Operating Officer (COO) at HNL Lab Medicine, bringing over 38 years of experience and extensive expertise to our team. Warren’s ability to diagnose and improve operational efficiency is foundational to accelerating our growth strategy as we expand our genetics and molecular capabilities. Warren is solution-oriented, a great listener and collaborator.
Warren joined HNL Lab Medicine as interim VP of Lab Operations in June 2021. Bringing his knowledge in scaling laboratory infrastructure and operations. Recognized as a strategic business partner, strong leader, and effective change manager. He was appointed Chief Lab Operations Officer in Sept 2021.
Warren began his career with MetPath Labs, in 1982. He started as a facilities maintenance mechanic. MetPath later became Quest Diagnostics. Warren later assumed the responsibility for Distribution and warehouse operations.
Warren left Quest and joined Medilabs in 1996 where he became Vice President of Operations. He oversaw purchasing, logistics, client service, phlebotomy and many other parts of lab operations. Medilabs was purchased by BioReference in April 1998, whereby he assumed the position of VP of Operations for the merged laboratory. He continued to perform all functions for the lab operations and in 2015 was named Senior VP and Chief Operating Officer for the third largest national laboratory with 1 billion in revenues.
He was a key member of the Executive team in which they sustained rapid growth of 20 consecutive years with at least 20% annual compounded growth. Warren oversaw and managed all area of the Lab operations including, Laboratory Operations, Phlebotomy, Customer service, Logistics, remote lab operations, material management, Operations Excellence, Referral testing, pre-analytic processing, and safety and facilities. At their peak they serviced over 50,000 patients a day. The BioReference team is credited for successful growth by building an operation focused on continued improvement, beating the competition providing better service consistently for patients and customers.
Warren played a key role with due diligence and integration for 15 acquisitions. They expanded significant remote laboratory operations on California, Texas, Florida, and Maryland. Played a major role expanding footprint and capabilities of GeneDx. Warren established professional and personal credibility, trust, and a sense of team thought out the entire organization. Known to all employees as an engaged, approachable leader strongly committed to the highest quality patient care, and customer service. Warren most recently was assigned a position to Genesis Healthcare regarding the life safety survey for a Nursing home operation in Cape May NJ.
Jordan Olson
Chair of Pathology at LVHN and Medical Director of HNL Lab Medicine
MD
Prior to joining HNL Lab Medicine and LVHN, Dr. Olson was Division Chief, Clinical Pathology Informatics at Geisinger Medical Laboratories. He served as a faculty member in the Geisinger Health System Clinical Informatics fellowship program and the Geisinger Medical Laboratory residency program.
He is a member of numerous professional organizations including the College of American Pathologists, American Society for Clinical Pathology, Pennsylvania Association of Pathologists, American Association of Blood Banks, and Association of Pathology Informatics.
Dr. Olson’s research has been featured in numerous peer-reviewed journals and national presentations in topics including:
Improved blood utilization strategies using informatics-based interventions
Computerized physician order entry and automated decisions support
Platelet rich plasma for tendon repair
Solid phase antibody testing in obstetric patients
Lisa W. Anthony
Senior Executive, Health Systems Partnerships
MS, MT, DLM
As Senior Executive, Health Systems Partnerships, Lisa Anthony is responsible for continuing the significant growth and geographical expansion of HNL Lab Medicine. She oversees the evaluation of partnership opportunities and strategies that includes establishing joint ventures, laboratory management agreements, and laboratory acquisitions.
Beginning as a technologist for Lehigh Valley Health Network’s hospital laboratory, Lisa has held various progressive leadership positions as HNL Lab Medicine evolved. She implemented the Customer Care and Marketing divisions and launched the Flow Cytometry, Molecular Diagnostics, and Cytogenetics laboratories.
As Vice President and then Senior Vice President of Operations, Lisa merged the clinical and support divisions at HNL Lab Medicine. Through the provision of quality Laboratory testing, HNL Lab Medicine continued to grow, resulting in her team expanding to more than 900 dedicated employees. In 2015, Lisa championed the architecture and orchestrated the move to a 102,000 Sq. Ft. laboratory. During this move and beyond, Lisa and her leadership team continued to provide excellent service to those patients and providers we serve by maintaining operations at multiple hospital-based testing laboratories, more than 55 Patient Centers, and a mobile phlebotomy service in Pennsylvania and New Jersey.
After earning her undergraduate degree in Laboratory Science at Penn State University, Lisa also earned a bachelor’s degree in Business Administration and a master’s degree in Organizational Management at Misericordia University. She is credentialed as a medical technologist and holds certification as a Diplomat in Laboratory Management from the American Society of Clinical Pathology.
Renu Bajaj
Associate Medical Director, Genomics
PhD FACMG
Renu Bajaj, Ph.D. FACMG, serves as the Associate Medical Director, Genomics. Dr. Bajaj received her Ph.D. in cytogenetics from the University of Delhi. She completed ABMGG Fellowships in clinical cytogenetics/genomics and molecular genetics/genomics at Yale University School of Medicine, Cytogenetics Lab in New Haven, CT, and Hartford Hospital. She is board-certified in laboratory genetics and genomics, and clinical cytogenetics.
Prior to joining HNL Lab Medicine, Dr. Bajaj held various positions such as Director, Clinical Cytogenetics and Genomics for St. Christopher’s Hospital for Children in Philadelphia, PA; Director, Clinical Cytogenetics for Integrated Oncology LabCorp Specialty Testing Group in NY, NY; Director, Clinical Cytogenetics for Thomas Jefferson University Hospital in Philadelphia, PA; Assistant Director, Clinical Cytogenetics for CSI Laboratories in Alpharetta, GA; and Supervisor, Cytogenetics Lab for Yale University School of Medicine in New Haven, CT.
She is a member of numerous professional organizations, including the American College of Medical Genetics, American Society of Human Genetics, and the Association for Molecular Pathology.
Publications
Ghosh R, Sahay S, Mehta R, Ghosh PK. Inhibition of Heterochromatin condensation in L Cell chromosome by Bibenzimidazole 33258 Hoechst. Indian J Exp Biol., 26: 333-336, 1988.
Mehta R, Guntur RM, Ghosh R, Ghosh PK. Inhibition of Heterochromatin condensation of human Y chromosome by Distamycin A. Indian J Exp Biol., 28(2):106-110, 1990.
Kamath A, Tara H, Xiang B, Bajaj R, He W, Li P. Double minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B and ELAVL2 in a patient with acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization. Cancer Genet Cytogenet. , 183(2):117-20, 2008.
Bajaj R, Xu F, Xiang B, Wilcox K, Diadamo AJ, Kumar R, Pietraszkiewicz A, Halene S, Li P. Evidence-based diagnostic genomic analysis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia. Molecular Cytogenetics, 4:3, 2011.
Massaro SA, Bajaj R, Pashankar FD, Ornstein D, Gallagher PG, Krause DS, Li P. Bi-Allelic Deletions Within 13q14 and Transient Trisomy 21 With Absence of GATA1s in Pediatric Acute Megakaryoblastic. Pediatr Blood Cancer, 57:516–9, 2011.
Gong P, Metrebian F, Dulau-Florea A, Wang Z-X, Bajaj R, Gulati G, Peiper SC, Gong J. Aberrant expression of CD56 on granulocytes and monocytes in myeloproliferative neoplasm, J Hematopathol, 6:127–134, 2013.
Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, Ruiz C, Curtis M, Fortina P, Ertel A, Liu C, Rui H, Visakorpi T, Bubendorf L, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Nevalainen MT. STAT5A/B gene locus undergoes amplification during human prostate cancer progression. Am j Pathol., 182(6): 2264-75, 2013.
Jamal SE, Li S, Bajaj R, Wang Z, Kenyon L, Glass J, Pang CS, Bhagavathi S, Peiper SC, Gong JZ. Primary central nervous system Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases. Brain Tumor Pathol, 31(4): 265-73, 2014.
Mardekian SK, Solomides CC, Gong JZ, Peiper SC, Wang ZX, Bajaj R. Comparison of chromogenic in situ hybridization and FISH for the evaluation of MDM2 amplification in adipocytic tumors. J Clin Lab Anal., 17:10, 2014.
Uppal G, Ly V, Wang ZX, Bajaj R, Solomides CC, Banks PM, Medeiros LJ, Peiper SC, Gong JZ. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of Hairy cell leukemia. Am J clin Pathol., 143(1): 120-5, 2015.
Wang Z, Simen B, Ying L, Goswami C, Davis K, Bajaj R, Gong JZ, Peiper SC: Validation of a next-generation sequencing panel for use in the clinical laboratory. Arch Pathol Lab Med. Apr; 139(4):508-17, 2015.
Shi Y, Solomides C, Gong J, Wang Z, Uppal G, Ly V, Peiper S, Bajaj R. Fluorescence In Situ Hybridization on Enriched CD138-Positive cells in Plasma Cell Myeloma. Acta Medica International, 2(2):168-174, 2015.
Mardekian S, Wang Z-X, Gong J, Uppal G, Peiper S, Bajaj R,. Genetic Heterogeneity of Philadelphia Chromosome-Positive Leukemias With a Spotlight on Two Cases: Relapsed Acute Lymphoblastic Leukemia and De Novo Acute Myeloid Leukemia. Am J Clin Pathol (2015) 144 (suppl_2): A232.
Holmes PJ, Peiper SC, Uppal GK, Gong JZ, Wang ZX, Bajaj R. Efficacy of DSP30-IL2/TPA for Detection of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Int J Lab Hematol. Oct;38(5): 483-489, 2016.
Pontoriero F, Silverman AM, Pascasio JM, Bajaj R. Nonkeratinizing Nasopharyngeal Carcinoma, Undifferentiated Type With Trisomy 2: A Case Report and Short Review of Cytogenetic and Molecular Literature. Pediatr Dev Pathol. 2020 Aug 5:1093526620945861. doi: 10.1177/1093526620945861. Epub ahead of print. PMID: 32755442.
Thales A. C. De Guimarães, Jenina E. Capasso, Nicholas R. Bello, Nutsuchar Wangtiraumnuay,Michelle D. Lingao, Wadakarn Wuthisiri, Yu‑Hung Lai, Erica S. Johnson, Mario Zanolli, Vikas Khetan,Renu Bajaj, Zi‑Xuan Wang, Stephen C. Peiper, Alex V. Levin. Chromosomal Microarray in Isolated Congenital and Developmental Cataract. The Pan-American Journal of Ophthalmology, 2021.
Kerry Kocher Brown
Medical Director, Genomics.
PhD, FACMG
Kerry Brown, Ph.D., is the Genomics Medical Director at HNL Lab Medicine. She earned her Ph.D. in genetics from Harvard Medical School where she investigated genetic causes of hearing loss. She completed a fellowship in clinical laboratory genetics through the Harvard Medical School Genetics Training Program, which included molecular genetics training at the Partners Healthcare Laboratory for Molecular Medicine, cytogenetics training at the Brigham and Women’s Hospital Cytogenetics Laboratory, and research in the field of cardiovascular genetics. Dr. Brown is board certified in clinical molecular genetics and clinical cytogenetics by the American Board of Medical Genetics.
She was previously a laboratory director at Connective Tissue Gene Tests (CTGT), which specialized in clinical molecular testing for rare genetic diseases and was an international leader in genetic testing for connective tissue disorders and skeletal dysplasias. Dr. Brown currently serves as the chair of the ClinGen Skeletal disorders variant curation expert panel and the co-chair of the ClinGen Skeletal disorders gene curation expert panel.
Dr. Brown is a fellow of the American College of Medical Genetics and Genomics (ACMG) and has served on the ACMG Laboratory Quality Assurance Committee, where she assisted in the development of guidelines for interpretation of copy number variation and for implementation of next-generation sequencing technologies in clinical laboratories.
Jessica Bargilione
Vice President of Marketing
MS, MBA
Jess has a B.S. in Education from East Stroudsburg University, a Master in Psychology from University of Phoenix and an MBA in Digital Marketing from Rutgers University.
As the Vice President of Marketing for HNL Lab Medicine, Jess is responsible for leading the marketing team as they work to showcase the exceptional capabilities of HNL Lab Medicine as we expand into additional markets and locations.
Rick Cardona
Vice President of Support Operations
In 2012, Rick was promoted to Administrator of Support Services. Due to HNL Lab Medicine’s significant growth, Rick led the design and subsequent relocation to a new 102,000 sq. ft, state of the art, diagnostics laboratory facility. During his career at HNL Lab Medicine, Rick has been instrumental in providing access to the patients we serve by opening 40 new patient centers.
“I am delighted to be given this opportunity,” said Rick. “This promotion allows me the opportunity to use all my experience and expertise to align our support operations for the future growth of HNL Lab Medicine.”
Before joining HNL Lab Medicine, Rick spent 21 years at Lehigh Valley Health Network. Rick served as Director, Logistical Support Services for 15 years. Among his many achievements included the implementation and management of a newly created centralized patient transport service, the development, and implementation of organizational-wide supply distribution and logistical support programs, mailroom automation, and printshop services.
Taking a break from the demands of running HNL Lab Medicine facilities and support operations, Rick enjoys spoiling his two dogs, golfing, swimming, pheasant hunting, trap and skeet shooting and target shooting. In addition, gardening and landscaping are relaxing pastimes.
David M. Confalone
Vice President of Finance
David M. Confalone, CPA, MBA, serves as Vice President of Finance at HNL Lab Medicine. He received his Bachelor of Science in Accounting from DeSales University in Center Valley, Pennsylvania and his Master of Business Administration from Alvernia University in Reading, Pennsylvania. He is licensed in the Commonwealth of Pennsylvania as a Certified Public Accountant. David is also General Electric Green Belt and LEAN Certified.
Prior to joining HNL Lab Medicine, he served in various positions including Chief Financial and Operating Officer for Advanced Dermatology Associates LTD in Allentown, Pennsylvania; Chief Financial Officer for Jaindl Companies in Orefield, Pennsylvania; Chief Financial Officer, Vice President of Finance and Administration for RPA Associates in Wyomissing, Pennsylvania; and Global Director, Finance and Cash Management for Penske in Reading, Pennsylvania.
He is a member of numerous professional organizations, including the American Institute of Certified Public Accountants and the Lehigh Valley Chapter of the Pennsylvania Institute of Certified Public Accountants.
Angela Connell
Vice President of Human Resources
PHR, SHRM-CP
Angela lives in Nazareth with her husband and 3 boys (ages 13, 10, 6). I would list what she does in her spare time but between work, school, sporting events and moving 3 kids around to practice, she doesn’t have any.
Ada Gazzillo
Vice President of Core Lab Operations.
Ada brings over 30 years of experience from BioReference Laboratories and Quest Diagnostics under her belt, Ada brings exceptional expertise to HNL Lab Medicine.
Ada began her career in the Toxicology department, and has since served in various roles, including Vice President of Pre-Analytical Operations, Director of Processing, and Manager of Client Services. Ada holds a Six Sigma Yellow Belt certification along with Data Analytics for Lean & Six Sigma Practitioners, which drives her passion for creating efficient, effective solutions and driving business growth. Ada obtained a Bachelor of Science from New Jersey State University and participates as a College of American Pathologists (CAP) Inspector.
Ada has a wealth of experience in the lab operations field, having built a solid reputation for delivering excellent client service, ensuring quality results, and providing for a healthy bottom line. She is highly skilled in developing and implementing business strategies to support financial and operational goals. In addition, her expertise in automating manual systems, creating department metrics, and leading process improvement initiatives will be a great asset to our team.
Amy Hoherchak
Vice President of Clinical Lab ACL Operations
Amy Hoherchak, MT (ASCP), currently serves as Vice President of Clinical Lab ACL Operations at HNL Lab Medicine. She received her Bachelor of Science in Medical Technology from the University of Scranton in Scranton, PA. Amy completed further training programs such as LEAN Silver Training at Henry Ford Health System in Detroit, MI and the Six Sigma Green Belt certification at Villanova University in Philadelphia, PA.
Prior to joining HNL Lab Medicine, she served in various leadership positions including Operations Director, Northeast Region for Geisinger Medical Laboratories in Wilkes Barre, PA and Laboratory Operations Manager for Lehigh Valley Hospital-Pocono in East Stroudsburg, PA. She has served in numerous positions within HNL Lab Medicine including Operations Director, Central Laboratory; and Manager, Automation and Specimen Management.
Brian Fanning
Vice President of Patient Experience
MBA
In November 2021, Brian accepted the role of Vice President of Patient Experience for HNL Lab Medicine. Brian is responsible for the growth and scale of the company's Patient Service Center (PSC) business division, including the overall management, operation, and financial performance of over 60 locations throughout Pennsylvania.
Brian lives in Bethlehem Township with his wife and two teenage sons. When not at the office, he most likely can be found at a hockey rink watching his son’s play for the Lehigh Valley Phantoms Youth hockey organization, coaching, officiating or playing.
Edward L. Mazuchowski
Chief, Forensic Pathology
MD, PhD
Caitlin Murphy
Clinical Laboratory Director
PhD
Dr. Caitlin Murphy is Clinical Laboratory Director of HNL Lab Medicine.
Dr. Murphy is board certified by the American Board of Medical Microbiology (ABMM). Prior to joining HNL, Dr. Murphy was an Assistant Professor at the University of Nebraska Medical Center, Department of Pathology and Microbiology and served as the Assistant Director of Clinical Microbiology at Nebraska Medicine. During this time, she also served as the CLIA Director for the Wyoming Public Health Laboratory.
Dr. Murphy received her Master of Science in Biological Sciences from the University of Nevada, Las Vegas and earned her Ph.D. in Microbiology at the University of Iowa. She completed her clinical fellowship in Microbiology at the University of Nebraska Medical Center and Nebraska Public Health Laboratory and is a member of the American Society of Microbiology (ASM), College of American Pathologists (CAP), and the Clinical and Laboratory Standards Institute (CLSI).
Eric Rounds
Vice President, Information Services And Technology
Jeffrey Wisotzkey
Clinical Laboratory Scientific Director
PhD, HCLD
Jeff Wisotzkey, Ph.D., HCLD, CC, currently serves as HNL Lab Medicine’s Clinical Laboratory Scientific Director. Dr. Wisotzkey received his doctoral degree in molecular biology from the University of Houston and he completed postdoctoral training at Pennsylvania State University’s Hershey Medical Center. He is a board-certified High Complexity Laboratory Director (HCLD) and Clinical Consultant (CC).
During his career, Dr. Wisotzkey has held various senior positions with clinical laboratories including Chief Scientific Officer and Clinical Laboratory Director for Diatherix-Eurofins and Madison Core Laboratories in Huntsville, Alabama; Vice President, Molecular Pathology and Laboratory Director for Genomind in King of Prussia, PA; Director of Molecular Pathology and Technical Director of Laboratory Operations for Central PA Alliance Laboratory in York, PA; and Technical Director, Molecular Diagnostics and Research for York Hospital in York, PA. He has facilitated the build out and implementation of several additional clinical laboratory services in smaller laboratories around the country.
Dr. Wisotzkey is an avid student and teacher of leadership and leadership communications. He also serves on numerous professional advisory boards and industry committees. He returned to HNL Lab Medicine following a four year hiatus during which he developed complex laboratory programs in Huntsville and Nashville. He previously served as Clinical Laboratory Director and Scientific Officer at HNL Lab Medicine.
Mini George Abraham
Chief of Hematopathology
MD, FCAP
Dr. Mini George Abraham received her MD from Trivandrum Medical College in Kerala, India. She completed her pathology residency and hematopathology fellowship at Drexel University College of Medicine in Philadelphia. She is certified by the American Board of Pathology in Anatomic and Clinical Pathology with added board certification in hematopathology. She is published in the areas of neuroendocrine carcinoma, Von Recklinghausen disease, and T-cell lymphoma. Dr. Abraham has served as a laboratory inspector for the College of American Pathologists (CAP) and previously held an academic appointment as assistant professor of pathology at Drexel University College of Medicine.
Publications
Precursor B- Cell Lymphoblastic Lymphoma:
Saloni Goyal, DO, Chun Siu, DO, Robert Decker, MD, Mini Abraham, MD, Rayna Abraham, OMS- III, Savitri Skandan MD
Plasmacytic neoplasm in a patient with chronic Immunosuppression: an unusual clinical presentation as shoulder mass.
Authors Alisha Hossain, DO (1), Emily Skutnik, DO (1), Rayna Abraham, OMS III (2), Robert Decker, MD (3), Mini Abraham, MD (4), Eliot Friedman, MD (3); (1) Department of Internal Medicine, Lehigh Valley Health Network, Allentown, PA (2) Philadelphia College of Osteopathic Medicine, Philadelphia, PA (3) Department of Hematology Oncology, Lehigh Valley Health Network, Allentown, PA (4) Department of Anatomic Pathology, Lehigh Valley Health Network, Allentown, PA
Neuroblastoma presenting as hip pain and skull prominence in a child
Authors: Hunter R. Hewitt, BS* Kimberly L. Fugok, DO* Marna Rayl Greenberg, DO* Andrew C. Miller, DO* Mini G. Abraham MD+ Richard J. Mazzaccaro, MD, PhD^
All authors affiliated with Lehigh Valley Health Network/USF MCOM Departments of Emergency and Hospital Medicine*, Pediatrics^, and Anatomic Pathology+ CC & I-78 Allentown, PA 18103
Eugene Alexandrin
Pathologist
MD
Dr. Alexandrin received his MD from Kharkov Medical Institute, USSR and completed his pathology residency at Hahnemann University, Philadelphia, Pa. He completed fellowship training with a Surgical Pathology Fellowship at the Lehigh Valley Hospital, Allentown, PA and an FNA fellowship at the Diagnostic Cytology Laboratory, Indianapolis. He is certified by the American Board of Pathology in Anatomic and Clinical Pathology with added board certification in Cytopathology. Dr. Alexandrin's areas of interest include endocrine pathology, head and neck pathology and cytopathology.
Haider Asad
Chief, Section of Gynecologic Pathology, Surgical Pathologist/Dermatopathologist
MD
Publications
Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases.Wang WL, Soslow R, Hensley M, Asad H, Zannoni GF, de Nictolis M, Branton P, Muzikansky A, Oliva E. Am J Surg Pathol. 2011 Apr;35(4):522-9. doi: 10.1097/PAS.0b013e31820ca624. PMID: 21383611
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
Köbel M, Kalloger SE, Carrick J, Huntsman D, Asad H, Oliva E, Ewanowich CA, Soslow RA, Gilks CB. Am J Surg Pathol. 2009 Jan;33(1):14-21. doi: 10.1097/PAS.0b013e3181788546. PMID: 18830127
Variants in hormone biosynthesis genes and risk of endometrial cancer.
Olson SH, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K, Faulkner S, Tommasi D, Egan D, Roy P, Wilcox H, Asya A, Modica I, Asad H, Soslow R, Zauber AG. Cancer Causes Control. 2008 Nov;19(9):955-63. doi: 10.1007/s10552-008-9160-7. Epub 2008 Apr 25. PMID: 18437511
Free PMC Article
Tactile-like corpuscles in gastric mucosa: a case report.
Salim S, Liu B, Mahmoodi M, Asad H, Hou SJ. World J Surg Oncol. 2006 Jul 5;4:39. PMID: 16822307
Free PMC Article
Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
Mahmoodi M, Asad H, Salim S, Kantor G, Minimo C. J Cutan Pathol. 2005 Aug;32(7):491-5. PMID: 16008693
Renal siderosis in donor allograft: pathologic and clinical sequelae.
Salim S, Asad H, Kumar MS, Brezin J, Heifets M, Fyfe B. Am J Transplant. 2004 Oct;4(10):1717-9. PMID: 15367231
Kirsten S.W. Bellucci
Co-Chief, Section of Dermatopathology
MD
Dr. Kirsten Bellucci attended Muhlenberg College (Allentown, PA) where she dual-majored in Biology and Theatre Arts, was a member of Phi Beta Kappa, graduated Summa Cum Laude with both a B.S. and a B.A., and was recognized with the Undergraduate Merit Award for exemplary character, personality, scholarship, and outstanding achievement.
She studied medicine at the Albert Einstein College of Medicine (Bronx, NY); taking an extra year to complete a post-Sophomore year Pathology Fellowship. Upon graduating with her M.D., she was also awarded the Irving M. Ratner Award for Excellence in Pathology.
She traveled to the University of Pennsylvania (Philadelphia, PA) to do residencies in both Anatomic Pathology and Clinical Pathology, and then remained at Penn to complete a fellowship in Surgical Pathology where she received the prestigious H.T. Enterline Fellowship Award.
Dr. Bellucci's Dermatopathology Fellowship training was done at Harvard University's Combined Dermatopathology Program (Boston, MA) which included instruction at Beth Israel Deaconess Medical Center, Massachusetts General Hospital, and Brigham & Women's Hospital under the tutelage of many beloved dermatopathology "greats" (Martin C. Mihm, Artur Zembowicz, Steven R. Tahan, George Murphy, and Lyn Duncan).
Dr. Bellucci is board certified by the American Board of Pathology in Anatomic Pathology and Clinical Pathology and by the American Boards of Pathology and Dermatology in Dermatopathology. She has taught medical students and resident physicians from Lehigh Valley Health Network (LVHN), University of South Florida (USF), Hershey Medical Center, University of Pennsylvania, and Harvard University Hospital Systems, and has published and presented in her field.
Dr. Kirsten Bellucci currently serves as a committee member on the Lehigh Valley Health Network Well-Being Council and has an academic appointment as Clinical Associate Professor at the University of South Florida (USF), Morsani College of Medicine.
Publications
Malignant neurocristic hamartoma: a tumor distinct from conventional melanoma and malignant blue nevus. Linskey KR, Dias-Santagata D, Nazarian RM, Le LP, Lam Q, Bellucci KS, Robinson-Bostom L, Mihm MC Jr, Hoang MP. Am J Surg Pathol. 2011 Oct;35(10):1570-7. doi: 10.1097/PAS.0b013e31822389b7. PMID: 21934481Anabolic steroids causing growth of benign tumors: androgen receptor in angiolipomas.
Syed SP, Brooks DG, Haupt HM, Bellucci K, Martin AM, Podolski V, Brooks JJ. J Am Acad Dermatol. 2007 Nov;57(5):899-900. No abstract available. PMID: 17939941
Tender erythema of the left lower extremity. Disseminated Aspergillus fumigatus infection with concurrent active cytomegalovirus infection (CMV).
Szyfelbein K, Lin JY, Bellucci KS, Williams JM. Arch Dermatol. 2007 Apr;143(4):535-40. No abstract available. PMID: 17438191
Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
Liang H, Wu H, Giorgadze TA, Sariya D, Bellucci KS, Veerappan R, Liegl B, Acs G, Elenitsas R, Shukla S, Youngberg GA, Coogan PS, Pasha T, Zhang PJ, Xu X. Am J Surg Pathol. 2007 Feb;31(2):304-10. PMID: 17255777
Erythematous papular rash on the upper back area. Caterpillar dermatitis, or erucism.
Williams CM, Bellucci KS, Liu V, Levins P. Arch Dermatol. 2006 Nov;142(11):1501-6. No abstract available. PMID: 17116846
Cellular nodules in congenital pattern nevi.
Xu X, Bellucci KS, Elenitsas R, Elder DE. J Cutan Pathol. 2004 Feb;31(2):153-9. PMID: 14690460
Alysia D. Browne
Pathologist
MD
John P. Brennan
Vice Chair, LVH-H
MD
Dr. Brennan received his medical degree from Jefferson Medical College in Philadelphia, PA. He completed his anatomic and clinical pathology residency, and surgical pathology fellowship at Thomas Jefferson University Hospital in Philadelphia, PA, and completed his cytopathology fellowship at The Lankenau Hospital in Wynnewood, PA. Dr. Brennan is certified by the American Board of Pathology in Anatomic and Clinical Pathology with added board certification in Cytopathology.
Peter Martin Clifford
FCAP, FASCP, Transfusion Medicine Director, Northern Campuses
DO/PhD
Dr. Peter Clifford is certified by the American Board of Pathology in Anatomic and Clinical Pathology and Transfusion Medicine/Blood Banking. Dr. Clifford received his medical degree from UMDNJ-School of Osteopathic Medicine in Stratford, NJ and holds a PhD from UMDNJ-Graduate School of Biomedical Sciences in Stratford. He completed his pathology residency at Hahnemann University Hospital/Drexel University in Philadelphia, PA and completed his fellowship at Mayo Clinic in Rochester, MN. Dr. Clifford is member of seven societies including the Association for the Advancement of Blood & Biotherapies (AABB), American Society for Apheresis (ASFA), and Pennsylvania Association of Pathologists (PAP). His professional interests include education, apheresis, and cellular therapy treatments.
Chunhua Cui
Chief, Section of Genitourinary Pathology
MD
Dr. Chunhua Cui received her MD from Dalian Medical University in China. She completed her anatomic and clinical pathology residency at Thomas Jefferson University Hospital followed by surgical pathology fellowship with emphasis on genitourinary pathology (GU) at the Hospital of University of Pennsylvania, both in Philadelphia, PA. She is certified by the American Board of Pathology in Anatomic and Clinical Pathology. Dr. Cui is a Clinical Assistant Professor at University of South Florida (USF), Morsani College of Medicine.
Elizabeth A. Dellers
Senior Vice Chair; Vice Chair, LVH-M; Chief, Division of Anatomic Pathology; Chief Section of Breast Pathology
MD, FCAP
Dr. Dellers received her MD from the University of Rochester School of Medicine and Dentistry, Rochester, NY and complete her pathology residency training at Temple University, Philadelphia,PA, followed by a Surgical Pathology Fellowship at Pennsylvania Hospital, Philadelphia, PA. She is certified by the American Board of Pathology in Anatomic and Clinical Pathology. At the Lehigh Valley Health Network, Dr. Dellers is a member of the Cancer Committee and the Breast Disease Management Team.
Her professional society memberships include the College of American Pathologists (CAP) where she has been a member of the Pathology Electronic Reporting Team (PERT) since 2018, working as part of that team to improve and standardize pathology reporting.
Dr. Dellers is a Clinical Assistant Professor at University of South Florida (USF) Morsani College of Medicine.
Publications:
Torous VF, Allan RW, Balani J, Baskovich B, Birdsong GG, Dellers EA, et al Exploring the College of American Pathologists Cancer Checklists: What They Are and What They Can Do For You Archives of pathology and laboratory medicine 145(4), 392-398. https://doi.org/10.5858/arpa.2020-0239-ED
Metzman, RA, Husson, MA and Dellers, EA: Renal Tubular Dysgenesis: A Description of Early Renal Maldevelopment in Siblings Pediatric Pathology, 13:239, 1993
Dellers EA, Dunn JC, DeSantis P, Aronchick CA: Identification of Blastocystis hominis by Colonic Brush Cytology Report of a Case Acta Cytologica, 36(5):757, 1992
Gerber W, Dellers EA and Putong P: Exaggerated Venous Mural Hypertrophy in Association with Metastatic Adenocarcinoma Of the Prostate J. Urology, 145(1): 151-3, 1991
Taber HW, Dellers EA and Lombardo LR: Menaquinone Biosynthesis in Bacillus subtilis: Isolation of men Mutants and Evidence For Clustering of men Genes J. Bact 145:321, 1981
A Non-randomized, Observational Trial of Short-term Pre-operative Endocrine Therapy in ER Positive Breast Cancer to Investigate Changes in Genomic Expression Using the Oncotype DX® Recurrence Score®, Aaron D. Bleznak MD, FACS; Elizabeth A. Dellers; B Glenn-Porter; Sharon R. Kimmel PhD, MHA; Heiwon Chung MD, FACS; C Yoshizawa; E Burke; D S. Davison; and C Chao (Poster)
Results of Re-Excision for Inadequate Margins Following Partial Mastectomy for Carcinoma of the Breast
Aaron Bleznak MD, FACS; Christine W. Du MD; Samuel Steerman MD; and Elizabeth Dellers MD (Poster)
Metzman RA, Husson MA, Dellers EA. Pediatr Pathol. 1993 Mar-Apr;13(2):239-48. PMID:8464784
Identification of Blastocystis hominis by colonic brush cytology. A case report.
Dellers EA, Dunn JC, DeSantis P, Aronchick CA. Acta Cytol. 1992 Sep-Oct;36(5):757-8. PMID:1523938
Extrauterine mixed mesodermal tumors. An immunohistochemical study.
Dellers EA, Valente PT, Edmonds PR, Balsara G. Arch Pathol Lab Med. 1991 Sep;115(9):918-20. Review. PMID:1718238
Exaggerated venous mural hypertrophy in association with metastatic adenocarcinoma of the prostate.
Gerber WL, Dellers EA, Putong PB. J Urol. 1991 Jan;145(1):151-3. PMID:1984079
Menaquinone biosynthesis in Bacillus subtilis: isolation of men mutants and evidence for clustering of men genes.
Taber HW, Dellers EA, Lombardo LR. J Bacteriol. 1981 Jan;145(1):321-7. PMID:6780514
Abstracts:
Bleznak, A, Dellers, E, Glenn-Porter, B, Kimmel, S, Chung, H, Yoshizawa, C, Burke, E, Davison, D And Chao, C. A Non-randomized Observational Trial of Short-term Pre-operative Endocrine Therapy in ER Positive Breast Cancer to Investigate Changes in Genomic Expression Using the Oncotype DX Recurrence Score. Poster presented at the American Society of Clinical Oncology Breast Symposium September 8-10, 2011.
Bleznak, A, Du, Christine C, Steerman, S, and Dellers, E Results of Re-excision for Inadequate Margins Following Partial Mastectomy For Carcinoma of the Breast. Poster presented at the 2011 National Consortium of Breast Centers Annual Meeting March 12-16, 2011
Santaniello, M, Chung, H and Dellers, E: Primary Breast Osteosarcoma: A Case Report Poster presented at Miami Breast Cancer Conference, Orlando, FL February 20-23, 2008
Dellers EA, Valente P, Edmonds PR, Balsara G: Extrauterine Mixed Mesodermal Tumors: An Immunohistochemical Study Arch Pathol Lab Med: 115:918-920, 1991 Abstract presented at the US and Canadian Academy of Pathology International Academy of Pathology 77th Annual Meeting, Washington, DC March 1988
Heba Y. Durra
Chief, Section of Pulmonary Pathology
MD
Dr. Durra received her MD from University of Jordan. She completed fellowship training in oncologic surgical pathology at Fox Chase Cancer Center in Philadelphia. She did her residency training in anatomic and clinical pathology at Temple University Hospital, also in Philadelphia. Prior to joining Health Network Laboratories, she was an associate professor of pathology at Temple University Hospital and Medical School, as well as medical director of the pathology laboratory at Bryn Mawr Gastroenterology Medical Specialists. She is certified by the American Board of Pathology in Anatomic and Clinical Pathology.
Publications
Fan Lin, M.D, PhD, Heba Abdallah, M.D, and Steven Meschter, M.D. Diagnostic Utility of CD10 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinoma in Fine-Needle Aspiration biopsy (FNAB) of the Liver. Diagnostic Cytopathology 2004; 30; 92-97
Kim V, Criner GJ, Abdallah HY, Gaughan JP, Furukawa S, Solomides CC. Small Airway Morphometry and Improvement in Pulmonary Function after Lung Volume Reduction Surgery. American Journal of Respiratory and Critical Care Medicine 2005 Jan. 1; 171(1): 40-7
T. Bhavsar, MD, G. Vincent, MD, H. Durra, MD, J. Khurana, MD, Y. Huang, MD, PhD. Primary Amyloidosis Involving Mesenteric Lymph nodes: Diagnosis by Fine-Needle Aspiration Cytology. Acta Cytologica 2011, 55(3):296-301
Durra H, Flieder D. Peripheral Squamous Cell Carcinoma of the Lung: Potential Pitfalls in Biopsy Interpretation. Pathology Case Reviews. 17(5):211-216, September/October 2012.
Stewart JI, D’Alonzo GE , Ciccolella DE, Patel NB, Durra H, Clauss HE. Reverse halo sign on chest imaging in a renal transplant recipient. Transpl Infect Dis. 2014 Feb;16(1):115-8
Wang C., Durra HY, Huang Y, Manucha V. Interobserver Reproducibility Study of the Histologic Patterns of Primary Lung Adenocarcinoma With Emphasis on a More Complex Glandular Pattern Distinct from the Typical Acinar Pattern. Int J Surg Pathol. 2014 Jan 29
Durstenfeld AL., Aneja A., Liu J., Durra H., Roehm PC., Facial nerve invasion by Basal cell carcinoma. Otol Neurotol. 2014 Mar;35(3):e121-2
Durra H, Khurana J, Flieder D. Mediastinal Adenofibroma. Histopathology, 2014 Sep;65(3):434-5
Kim V, Oros M, Durra H, Kelsen S, Aksoy M, Cornwell WD. Rogers TJ, Criner GJ. Chronic Bronchitis and Current Smoking are Associated with More Goblet Cells in Moderate to Severe COPD and Smokers without Airflow Obstruction. PloS One. 2015 Feb 3;10(2):e0116108
Kim V, Cornwell WD, Oros M, Durra H, Criner GJ, Rogers TJ. Plasma Chemokine Signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease. BMC Pulm Med 2015 Sep 30;15:111
Lisa E. Dwyer-Joyce
Chief, Section of Cytopathology
MD
Chief, Section of Cytopathology. Dr. Dwyer-Joyce received her MD from the Royal College of Surgeons in Dublin, Ireland. She completed pathology residency at Medical College of Pennsylvania/Hahnemann University Hospital. She completed fellowship training in cytopathology at Hahnemann University Hospital and surgical pathology fellowship training at the University of Pennsylvania’s Pennsylvania Hospital, both in Philadelphia.
Following this she was appointed Clinical Assistant Professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine. Prior to joining Health Network Laboratories, she was director of cytopathology at Pennsylvania Hospital. She has taught medical students and residents at Pennsylvania Hospital and the Perelman School of Medicine of the University of Pennsylvania. She is certified by the American Board of Pathology in Anatomic and Clinical Pathology with added subspecialty board certification in Cytopathology.
Publications
Swami VK, Dwyer-Joyce L,. Anti-Pr Cold Agglutinin Disease. ASCP Check Sample. Transfusion Medicine, 1997; 40(7): 83-91.
Lee DJ, Sigel B, Swami VK, Justin JR, Gahtan V, O’Brien SP, Dwyer-Joyce L, Feleppa, EJ, Roberts AB, Berkowitz HD. Determination of carotid plaque risk by ultrasonic tissue characterization. Ultrasound in Medicine and Biology 1998; 24(9):1291-1299.
Swami VK, Dwyer-Joyce L. Diagnosing Plasma Cell Leukemia. Laboratory Medicine. 2000; 31(6): 312-315
Dwyer-Joyce L, Galindo LM, Shienbaum AJ, Garcia FU. Atypical hemangioma of the breast: A diagnostic pitfall in breast fine-needle aspiration. Diagn Cytopathol. 2001 Mar; 24(3): 215-18.
Maity A, Shu HG, Judkins AR, Fisher MJ, Dwyer-Joyce LEA, and Vaughn DJ. Testicular seminoma 16 years after treatment for CNS germinoma. J. Neuro-Onc 70: 83-85, 2004
Boockvar JA, Stiepel M, Malhotra NR, Dolinskas C, Dwyer-Joyce L, LeRoux PD. Dural cavernous angioma of the posterior sagittal sinus: a case report. Surgical Neurol 63: 178-181, 2005.
Biko DM, Spanier JF, Nagamine M, Dwyer-Joyce L, Ball DS. Persistent secondary postpartum hemorrhage after uterine artery embolization. J. Vasc Interv Radiol. 2009 Feb;20(2):279-281.
Dinesh KP, Owolabi A, Dwyer-Joyce L, Cronin PM, Schimmer BM, Mo GP. Temporal artery vasculitis in young: a report of two cases. Rheumatol Int. 2010 Aug 30(10);1393-6.doi:10.1007/s00296-009-1084-3.
Lang SS, Schuster JM, Smith LJ, Dwyer-Joyce L, Welch W et al. Hemorrhage into Synovial Cysts as a Cause of Acute Radicular Symptoms: Report of Seven Cases and Review of the Literature. J. Spine Neurosurg 2:1. Doi:10.4172/2325-9701.1000106
Tunde Farkas
Pathologist
After receiving her M.D. in Hungary, Dr. Farkas completed her residency in Anatomic and Clinical Pathology at Barnes-Jewish Hospital, an affiliated teaching hospital of Washington University School of Medicine in St. Luis. She completed fellowship trainings in Surgical Pathology and Cytopathology at Washington University. She also holds a certificate degree from the Wharton School of Business.
Before joining HNL Lab Medicine, Dr. Farkas served as chair of pathology at Phoenixville Hospital. Her previous faculty experience includes Temple University, Pennsylvania Hospital, and the Hospital of the University of Pennsylvania. She is a Diplomat of the American Board of Pathology in Anatomic and Clinical pathology with an added certification in Cytopathology.
Elizabeth Gersbach
Pathologist
MD
Shereen M.F. Gheith
Chief, Section of Hematopathology Chief, Section of Molecular Pathology
MD, PhD
Publications
Shereen Gheith MD, Chief, Section of Hematopathology & Clinical Laboratory Medicine and Dennis Cornfield, MD, Education Coordinator coauthored a publication entitled “ Promyelocytic sarcoma present with spinal cord compression and treated successfully with surgical debulking and the PETHEMA regimen for acute promyelocytic leukemia ”. Case Reports in Clinical Pathology. 2015; 2(3).
Shereen Gheith MD, Chief, Section of Hematopathology & Clinical Laboratory Medicine coauthored a publication entitled “Primary dural lymphoblastic B-cell lymphoma: a rare subtype of aggressive dural lymphoma”. J Hematopathol. 2015.
Immunoblastic follicular lymphoma: a very unusual transformation of low-grade follicular lymphoma.
Authors: Gheith S; Hematopathology Section, Department of Pathology, Health Network Laboratories/Lehigh Valley Health Network, Allentown, PA, 18103. Electronic address: Shereen_M.Gheith@lvhn.org. Cornfield D; Hematopathology Section, Department of Pathology, Health Network Laboratories/Lehigh Valley Health Network, Allentown, PA, 18103. Chen W; Molecular Diagnostics Section, Cancer Genetics, Rutherford, NJ, 07070. Singh-Kahlon P; Cytogenetics Section, Cancer Genetics, Rutherford, NJ, 07070.
Ahmed B; Hematology/Medical Oncology Section, Department of Medicine, Lehigh Valley Health Network, Allentown, PA, 18103.
Source: Human Pathology [Hum Pathol] 2014 Nov; Vol. 45 (11), pp. 2359-63. Date of Electronic Publication: 2014 Aug 13.
Agostino NM, Ahmed B, Popescu D. Gheith S, Int J Clin Exp Pathol. 2011 Mar;4(3):322-6. Epub 2011 Mar 22. Review. PMID: 21487529 Free PMC Article
Percentage of {gamma}{delta} T cells in panniculitis by paraffin immunohistochemical analysis.
Roullet M, Gheith SM, Mauger J, Junkins-Hopkins JM, Choi JK. Am J Clin Pathol. 2009 Jun;131(6):820-6. doi: 10.1309/AJCPMG37MXKYPUBE. PMID: 19461088 Free Article
Small lymphocytic lymphoma/chronic lymphocytic leukemia in a pelvic myelolipoma.
Gheith S, Boulay R, Cornfield D. Int J Clin Exp Pathol. 2009;2(1):95-8. Epub 2008 Jan 31. PMID: 18830383 [PubMed] Free PMC Article
Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
Cornfield DB, Gheith SM. Cytometry B Clin Cytom. 2009 May;76(3):213-7. doi: 10.1002/cyto.b.20455. PMID: 18803280 Free Article
A third case of chronic eosinophilic leukemia with the (8;9)(p23;p24) translocation.
Cornfield DB, Gheith SM, Friedman EL. Cancer Genet Cytogenet. 2008 Aug;185(1):60-1. doi: 10.1016/j.cancergencyto.2008.04.018. No abstract available. PMID: 18656698
Adhesion- and degranulation-promoting adapter protein is required for efficient thymocyte development and selection.
Wu JN, Gheith S, Bezman NA, Liu QH, Fostel LV, Swanson AM, Freedman BD, Koretzky GA, Peterson EJ.
J Immunol. 2006 Jun 1;176(11):6681-9. PMID: 16709827 Free Article
PRAM-1 is required for optimal integrin-dependent neutrophil function.
Clemens RA, Newbrough SA, Chung EY, Gheith S, Singer AL, Koretzky GA, Peterson EJ.
Mol Cell Biol. 2004 Dec;24(24):10923-32. PMID: 15572693 Free PMC Article
Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling.
Boerth NJ, Sadler JJ, Bauer DE, Clements JL, Gheith SM, Koretzky GA. J Exp Med. 2000 Oct 2;192(7):1047-58.PMID:11015445 Free PMC Article
Shanth A. Goonewardene
Vice Chair Quality and Clinical Operations; Chief, Section of Gastrointestinal Pathology
MD
Publications
The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients t reated with surgery alone.
Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.Cancer. 2004 Jun 1;100(11):2317-27. PMID: 15160334 Free Article
Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Zimmerman RL,Goonewardene S, Fogt F. Mod Pathol. 2001 Aug;14(8):748-51. PMID:11504833 Free Article
Diagnostic utility of BCA-225 in detecting adenocarcinoma in serous effusions.
Zimmerman RL, Goonewardene S,Fogt F. Anal Quant Cytol Histol. 2000 Oct;22(5):353-7. PMID:11064810
Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions.
Zimmerman RL, Fogt F, Goonewardene S. Cancer. 2000 Aug 25;90(4):230-4. PMID:10966563
Jillian R. Grau
Vice Chair, LVH; Associate Chief, Division of Anatomic Pathology; Chief Section of Histopathology
MD
Dr. Grau received her MD from Drexel University College of Medicine, Philadelphia, Pa. She completed her pathology residency as well as her fellowship training in Surgical and Gastrointestinal/Liver pathology at the Hospital of the University of Pennsylvania, Philadelphia, Pa. Dr. Grau is certified by the American Board of Pathology in Anatomic and Clinical pathology. She is published in the areas of gastrointestinal and oncologic pathology and has presented on topics including ulcerative colitis at national meetings. Dr. Grau’s special interests include immunohistochemistry and pathology of the gastrointestinal tract and liver. Dr. Jillian Grau is a Clinical Assistant Professor at University of South Florida (USF), Morsani College of Medicine.
Publications
Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer.
Prabakaran I, Grau JR, Lewis R, Fraker DL, Guvakova MA. J Thyroid Res. 2011;2011:979840. doi: 10.4061/2011/979840. Epub 2011 Oct 20. PMID: 22046576 [PubMed] Free PMC Article
Journal of Thyroid Research. 2011; 2011: 979840.
Sullivan M, Grau J, Shah S. Balloon Extraction of an Intraductal Tubulopapillary Neoplasm of the Bile Duct During Endoscopic Retrograde Cholangiopancreatography. American College of Gastroenterology Case Reports Journal. 2020; 7(11): p e00481
Asad-ur-Rahman FNU, Khan MT, Shah M, Grau J, Shah H. Macroscopic Findings in Microscopic Colitis: Two Case Reports and a Review of Literature. Gastroenterol Hepatol. 2017. Open Access 7(4): 00245.
Grau J, Sachais B. LDL Apheresis for Patients with Severe Hypercholesterolemia. American Society of Clinical Pathology, Check Sample. 2005; 48(8): 93-107.
Reactive versus neoplastic lymphoid follicles: proliferation and death versus quiescence and staying alive.
Glidden D, Grau J, Bagg A. Br J Haematol. 2004 Sep;126(6):757. No abstract available. PMID: 15352977 Asad-ur-Rahman FNU, Khan MT, Shah M, Grau J, Shah H. Macroscopic Findings in Microscopic Colitis: Two Case Reports and a Review of Literature. Gastroenterol
British Journal of Haematology. 2004; 126(6): 757.
Youming Huan
Chief, Section of Ear, Nose & Throat Pathology
MD
Michael W. Johnson
Medical and Forensic Pathologist/Neuropathologist
PhD, MD
Publications
Solid pseudopapillary neoplasm, pancreas type, presenting as a primary ovarian neoplasm.
Stoll LM, Parvataneni R, Johnson MW, Gui D, Dorigo O, Sullivan P. Hum Pathol. 2012 Aug;43(8):1339-43. doi: 10.1016/j.humpath.2011.12.018. Epub 2012 Apr 24. PMID: 22534259
Axonal injury in young pediatric head trauma: a comparison study of β-amyloid precursor protein (β-APP) immunohistochemical staining in traumatic and nontraumatic deaths.
Johnson MW, Stoll L, Rubio A, Troncoso J, Pletnikova O, Fowler DR, Li L. J Forensic Sci. 2011 Sep;56(5):1198-205. doi: 10.1111/j.1556-4029.2011.01814.x. Epub 2011 May 19. PMID: 21595698
Papillary tissue fragments in cervicovaginal (Pap) smears: cytomorphologic characteristics and clinicopathologic significance.
Stoll LM, Johnson MW, Ali SZ. Diagn Cytopathol. 2011 Sep;39(9):657-62. doi: 10.1002/dc.21443. Epub 2010 Oct 14. PMID: 20949454
High-grade prostatic sarcoma seen in a catheterized urine specimen: case report and differential diagnosis.
Stoll LM, Johnson MW, Rosenthal DL. Diagn Cytopathol. 2011 Oct;39(10):762-6. doi: 10.1002/dc.21545. Epub 2010 Oct 1. PMID: 20890999
Glioblastoma multiforme in the Muir-Torre syndrome.
Binder ZA, Johnson MW, Joshi A, Hann CL, Griffin CA, Olivi A, Riggins GJ, Gallia GL. Clin Neurol Neurosurg. 2011 Jun;113(5):411-5. doi: 10.1016/j.clineuro.2010.12.011. Epub 2011 Feb 1. PMID: 21288634
Acute myeloid leukemia with myelodysplasia-related changes with erythroid differentiation involving pleural fluid: a case report and brief cytopathologic review.
Stoll LM, Duffield AS, Johnson MW, Ali SZ. Diagn Cytopathol. 2011 Jun;39(6):451-4. doi: 10.1002/dc.21470. Epub 2010 Oct 17. Review. PMID: 20954271
Rapid malignant transformation of low-grade astrocytomas: report of 2 cases and review of the literature.
Frazier JL, Johnson MW, Burger PC, Weingart JD, Quinones-Hinojosa A. World Neurosurg. 2010 Jan;73(1):53-62; discussion e5. doi: 10.1016/j.surneu.2009.05.010. Epub 2009 Aug 7. Review. PMID: 20452869
Lipoglioblastoma: a lipidized glioma radiologically and histologically mimicking adipose tissue.
Johnson MW, Lin D, Smir BN, Burger PC. World Neurosurg. 2010 Feb;73(2):108-11. doi: 10.1016/j.surneu.2009.07.036. Epub 2009 Oct 13. PMID: 20860936
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK. Cancer Cytopathol. 2010 Dec 25;118(6):441-9. doi: 10.1002/cncy.20108. Epub 2010 Sep 9. PMID: 20830690
Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
Johnson MW, Eberhart CG, Perry A, Tihan T, Cohen KJ, Rosenblum MK, Rais-Bahrami S, Goldthwaite P, Burger PC. Am J Surg Pathol. 2010 Dec;34(12):1783-91. doi: 10.1097/PAS.0b013e3181fd66c3. PMID: 21107083
Cytologic diagnosis and differential diagnosis of lung carcinoid tumors a retrospective study of 63 Cases with histologic correlation.
Stoll LM, Johnson MW, Burroughs F, Li QK. Cancer Cytopathol. 2010 Dec 25;118(6):457-67.PMID:21243734
Intramedullary amputation neuromas associated with spinal ependymomas.
Johnson MW, Burger PC. Am J Surg Pathol. 2009 Apr;33(4):639-43. doi: 10.1097/PAS.0b013e31818fe3c9. PMID: 19065100
Angiocentric glioma: a case series.
Shakur SF, McGirt MJ, Johnson MW, Burger PC, Ahn E, Carson BS, Jallo GI. J Neurosurg Pediatr. 2009 Mar;3(3):197-202. doi: 10.3171/2008.11.PEDS0858. Review. PMID: 19338465 Free PMC Article
Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I, DeClue JE, Rust H, Vu PA, Kutzner H, Rütten A, Kaddu S, Sander CA, Volkenandt M, Johnson MW, Vinters HV, Wienecke R. J Cutan Pathol. 2003 Mar;30(3):174-7. PMID: 12641776
Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosis-associated cortical tubers.
Johnson MW, Miyata H, Vinters HV. Acta Neuropathol. 2002 Aug;104(2):188-96. Epub 2002 Jun 5. PMID: 12111362
Hamartin and tuberin expression in human tissues.
Johnson MW, Kerfoot C, Bushnell T, Li M, Vinters HV. Mod Pathol. 2001 Mar;14(3):202-10. PMID: 11266527 Free Article
Hamartin expression and interaction with tuberin in tumor cell lines and primary cultures.
Catania MG, Johnson MW, Liau LM, Kremen TJ, deVellis JS, Vinters HV. J Neurosci Res. 2001 Feb 1;63(3):276-83. PMID: 11170177
The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.
Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, Hall A. Nat Cell Biol. 2000 May;2(5):281-7. PMID: 10806479
Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.
Johnson MW, Emelin JK, Park SH, Vinters HV. Brain Pathol. 1999 Jan;9(1):45-54. PMID: 9989450
Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model : interactions between lipoprotein metabolism, autoimmune disease, and atherogenesis.
Gu L, Johnson MW, Lusis AJ. Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):442-53. PMID: 9974430 Free Article
Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes.
Vinters HV, Park SH, Johnson MW, Mischel PS, Catania M, Kerfoot C. Dev Neurosci. 1999 Nov;21(3-5):248-59. Review. PMID: 10575248
Isolation and characterization of synaptoneurosomes from single rat hippocampal slices.
Johnson MW, Chotiner JK, Watson JB. J Neurosci Methods. 1997 Dec 1;77(2):151-6. PMID: 9489891
Supriya Kuruvilla
Vice Chair, LVH-S
MBBS, MD
Dr. Supriya Kuruvilla received her MBBS degree from Government Medical College (BJMC), Pune, India and her MD from the Armed Forces Medical College, Pune, India. She then completed a four-year residency in Anatomic Pathology at the University of Texas Medical School in Houston, TX.
Dr. Kuruvilla received fellowship training in Forensic Pathology at the Harris County medical examiner's office in Houston, TX and Pediatric Pathology at Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
She is certified by the American Board of Pathology in Anatomic, Forensic, and Pediatric Pathology. She is a fellow of the College of American Pathologists (CAP) and National Association of Medical Examiners (NAME).
Devika Lal MD
MD
Devika Lal, MD, currently serves as a pathologist. Dr. Lal received her medical degree from the Temple University School of Medicine, and she completed a combined anatomic and clinical pathology residency at Drexel University College of Medicine/Hahnemann University Hospital in Philadelphia. She completed a fellowship in blood banking/transfusion medicine at the New York Blood Center and Columbia University Medical Center in New York. Dr. Lal is board certified in Anatomic/Clinical Pathology and Blood Banking/Transfusion Medicine.
Prior to joining HNL Lab Medicine, she held a faculty position at Rutgers University Robert Wood Johnson (RWJ) Medical School in New Brunswick, New Jersey. Additionally, Dr. Lal worked as a transfusion medicine pathologist at RWJ University Hospital and served as Director of Transfusion Medicine at both University Hospital in Newark, NJ and CareWell Health in East Orange, NJ.
During her undergraduate years, she worked at the Center for Neurodegenerative Disease Research, where she studied a transgenic mouse model of tau pathology in astrocytes leading to neurodegeneration.
Samuel D. Land
Medical and Forensic Pathology
MD
Elsie Lee
Chief of Transfusion Medicine
MD, FASCP
Dr. Elsie Lee received her medical degree from Upstate Medical University in Syracuse, NY. and completed her anatomic and clinical pathology residency at the University of Pittsburgh Medical Center in Pittsburgh, PA, followed by an hematopathology fellowship at the University of Iowa in Iowa City. She completed her transfusion medicine/blood banking fellowships at Mayo Clinic in Rochester, MN, and the University Hospital at Stony Brook in NY. She is certified by the American Board of Pathology in Anatomic and Clinical Pathology, Hematology and Blood Banking/Transfusion Medicine.
Dr. Lee is a member of the Association for the Advancement of Blood & Biotherapies (AABB), Mayo Clinic Alumni Association, American Society for Clinical Pathology, and a past member of the Residency Program Directors Section of the Association of Pathology Chairs. She is an Assistant Professor with appointment in the Department of Medical Education and Department of Pathology and Cell Biology at USF Health Morsani College of Medicine. Her areas of expertise and research include Transfusion Medicine and Hematopathology.
Publications:
Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging. Marios A Gavrielides, Brigitte M Ronnett , Russell Vang, Stephanie Barak, Elsie Lee, Paul N Staats, Erik Jenson, Priya Skaria, Fahime Sheikhzadeh, Meghan Miller, Ian S Hagemann, Nicholas Petrick, Jeffrey D Seidman. Arch Pathol Lab Med2021 Dec 1;145(12):1516-1525. PMID: 33635941
CPIP-K Case 11: Transfusion Medicine - Transfusion Reactions: A practical, Case-Based Guide to Quick and Accurate Diagnosis. Desai D and Lee E. CAP Clinical Pathology Improvement Program Learning Module November 2018
Secure Text Messaging in Transfusion Medicine. Can Texting Decrease Wastage. Melanie Estrella, Elsie Lee. Abstract accepted for poster presentation at AABB Annual Meeting Oct 2017. Transfusion Journal Supplement Sept 2017.
Blue Brain: A Case of Unexpected Discoloration of the Brain at Autopsy Secondary to Methylene Blue and Review of the Literature. Evan Stern, Elsie Lee, Isabel Almira Suarez. Abstract accepted for poster presentation at ASCP Annual Meeting in Sept 2017 and published in citable form in ASCP publication.
ALK Positive Primary CNS Anaplastic Large T-cell Lymphoma: A Unique Case Presentation. Amar Jariwala, Isabel Almira Suarez, Elsie Lee. Abstract accepted for poster presentation at CAP Annual Meeting in Oct 2017. Published in Web supplement to the September 2017 issue of the Archives of Pathology and Laboratory Medicine.
Extramedullary Haematopoiesis Presenting with Cardiac Tamponade in a Patient with Polycythaemia Vera. Haroun, Faysal; Elkis, Viktoria; Chen, Anne; Lee, Elsie. BMJ Case Rep. 2017 Aug 10; 2017. PMID: 28798246
Synchronous Ductal Carcinoma In-Situ and Intravascular Large B-cell Lymphoma of the Breast. Fadi Alakeel, Elsie Lee, Marilyn Baird-Howell, Samantha Easley. Applied Immunohistochemistry & Molecular Morphology 2017 Mar. PMID: 28582274
Discordance between Cobas BRAF V600 Testing and VE1 Immunohistochemistry in a Melanoma Patient with Bone Marrow Metastases. Rapisuwon S, Busam KJ, Parks K, Chapman PB, Lee E, Atkins MB. American Journal of Dermatopathology 2016 Sep; 38(9):687-9. PMID: 27541170
Concurrent Presentation of Waldenstrom's Macroglobulinemia and Angioimmunoblastic T-Cell Lymphoma. Amar R Jariwala, Fadi Alakeel, Elsie Lee and Donald Karcher. Abstract accepted for presentation at the USCAP Meeting 2016.
Outcomes of the Massive Transfusion Protocol in the Non-Trauma Population. M.E. Schroeder, Z Al-harbi, J Hartenstine, R Amdur, J Dunne, E Lee, B Sarani. Abstract accepted as poster presentation at the Annual Meeting of the American Association for the Surgery of Trauma and Clinical Congress of Acute Care Surgery held in Sept 2014.
Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA, A Case Report and Review of the Literature. Schallheim Jason, Lee Elsie. Winner of the GW Resident Research Award, case report category 2011.
Massaro and Hany Aly. Red Blood Cell Transfusion, Feeding and Necrotizing Enterocolitis in Preterm Infants. Mohamed El-Dib, Sherry Narang, Elsie Lee, An N. J Perinatol 2011 Mar; 31 (3):183-7.
Warfarin Coagulopathy Monitoring and Treatment Strategies. Codispoti Kari-Elise, Lee Elsie. ASCP Check Sample 2010.
The Partial D Phenotype: laboratory diagnosis and clinical implications. Codispoti Kari-Elise, Lee Elsie. ASCP Check Sample October 2009.
Wound Healing Potential of Freeze-Dried Outdated Platelets. Sum R, Hager S, Dee J, Rudolph A, Orser C, Lee E, Ho D. Transfusion. 2005; 45(Suppl): 24A.
Platelet Surface Markers Remain Viable After Several Days After Outdating. Hager S, Dee J, Rudolph A, Orser C, Lee E, Ho D. Transfusion. 2005(Suppl); 45: 75A.
ABO Phenotype is Associated with Variation in the Incidence of Sepsis in the Hospitalized Very Low Birth Weight (VLBW) Neonates. Aly H, Mack E, Tanveer A, Lee E, Patel K, El-Mohandes AE. Pediatric Research. 2004; 55: 399A-400A.
Does the Age of Transfused Blood Influence Outcomes of the Very Low Birth Weight Infants (VLBWI)? Mack E, Tanveer A, Massaro AN, Lee ES, Patel K, Aly H. Pediatric Research. 2004; 55:306A.
Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/Human model. Zhong RK, Donnenberg AD, Shultz LD, Swerdlow SH, Lee ES, Griffin DL, Ball ED. Leukemia Research 20(7); 581-9, July 1996.
The association of Epstein-Barr virus with smooth muscle tumors occurring after organ transplantation. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS. New England Journal of Medicine 332(1):19-25, January 5, 1995.
Effect of lecithin: cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. Bisgaier CL, Sachev OP, Lee ES, Williams KJ, Blum CB, Glickman RM. Journal of Lipid Research 28; (6):693-703; June 1987
A method to screen apolipoprotein polymorphisms in whole plasma: description of apolipoprotein A-IV variants in dyslipidemias and a reassessment of apolipoprotein A-I in Tangier’s disease. Bisgaier CL, Lee ES, Glickman RM. Biochimica et Biophysica Acta 918; (3):242-249, April 24, 1987
Sherry Q. Li
Pathologist
MD, PhD
Publications
Elevated levels and distinct patterns of expression of A-type cyclins and their associated cyclin-dependent kinases in male germ cell tumors.
Liao C, Li SQ, Wang X, Muhlrad S, Bjartell A, Wolgemuth DJ. Int J Cancer. 2004 Feb 20;108(5):654-64. PMID: 14696091
Detection of hTERT mRNA in colonic brush specimens as an adjunct to cytopathologic diagnosis of colonic adenocarcinoma.
Li SQ, Sheng ZM, Baili Y, Erozan YS, O'Leary TJ. Acta Cytol. 2002 Nov-Dec;46(6):1069-74. PMID: 12462084
Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1.
Liao C, Wang XY, Wei HQ, Li SQ, Merghoub T, Pandolfi PP, Wolgemuth DJ. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6853-8. Epub 2001 May 29.PMID:11381140 Free PMC Article
Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis.
Shaker R, Milbrath M, Ren J, Toohill R, Hogan WJ, Li Q, Hofmann CL. Gastroenterology. 1995 Nov;109(5):1575-82.PMID:7557141
Swallowing and esophageal function in Parkinson's disease.
Johnston BT, Li Q, Castell JA, Castell DO. Am J Gastroenterol. 1995 Oct;90(10):1741-6. Review.PMID:7572887
Manometric determination of esophageal length.
Li Q, Castell JA, Castell DO. Am J Gastroenterol. 1994 May;89(5):722-5.PMID:8172145
Coordination of deglutition and phases of respiration: effect of aging, tachypnea, bolus volume, and chronic obstructive pulmonary disease.
Shaker R, Li Q, Ren J, Townsend WF, Dodds WJ, Martin BJ, Kern MK, Rynders A. Am J Physiol. 1992 Nov;263(5 Pt 1):G750-5.PMID:1443150
Mechanisms of airway protection and upper esophageal sphincter opening during belching.
Shaker R, Ren J, Kern M, Dodds WJ, Hogan WJ, Li Q. Am J Physiol. 1992 Apr;262(4 Pt 1):G621-8.PMID:1566845
Maximo Llaudes
Vice Chair, LVH-P
MD
Victoria Loven
Pathologist
MD, FCAP
Publications
Thalidomide-resistant HIV-associated aphthae successfully treated with granulocyte colony-stimulating factor.Manders SM, Kostman JR, Mendez L, Russin VL. J Am Acad Dermatol. 1995 Aug;33(2 Pt 2):380-2.PMID:7542291
Fine-needle aspiration of dermoid cyst of the pancreas: a case report.
Markovsky V, Russin VL. Diagn Cytopathol. 1993;9(1):66-9.PMID:8458286
Male breast lesions: gynecomastia and its distinction from carcinoma by aspiration biopsy cytology.
Russin VL, Lachowicz C, Kline TS. Diagn Cytopathol. 1989;5(3):243-7.PMID:2791831
Psammoma bodies in neuroendocrine carcinoma of the uterine cervix.
Russin VL, Valente PT, Hanjani P. Acta Cytol. 1987 Nov-Dec;31(6):791-5.PMID:3425140
CMV colitis mimicking Crohn's disease in a patient with acquired immune deficiency syndrome (AIDS).
Caroline DF, Hilpert PL, Russin VL. Can Assoc Radiol J. 1987 Sep;38(3):227-8.PMID:2821006
Sajjad Masood Malik
Pathologist
MD
Dr. Malik received his MD from Drexel University College of Medicine in Philadelphia. He completed his anatomic and clinical pathology residency at Thomas Jefferson University Hospital, where he served as chief resident. Dr. Malik completed his surgical pathology fellowship at Fox Chase Cancer Center in Philadelphia. He is certified by the American Board of Pathology in Anatomic and Clinical Pathology. A former member of the Medical Record and Utilization Committee and associate AP/CP pathologist at Schuylkill Medical Center, Dr. Malik’s research and publications focus on Epstein-Barr viral infection, pilomatrix carcinoma of the thoracic spine, esophageal squamous cell carcinoma and inflammatory pseudopolyps in non-inflammatory bowel disease patients.
Dr. Malik has been appointed as the Educational Director because of his interest in educating students, residents, and colleagues in pathology. He has worked on developing the curriculum for fourth year USF medical students who are interested in pursuing a career in pathology.
Dr. Malik also has an interest in digital pathology and is currently working on a team to initiate digital pathology into the day to day workflow at HNL.
Crystal Magno
Forensic Pathologist
MD
Crystal Magno, MD, currently serves as a pathologist. Dr. Magno received her medical degree from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, PA and completed residency training in anatomic and clinical pathology at the Hospital of the University of Pennsylvania in Philadelphia, PA. She completed fellowship training in forensic pathology at the State of Maryland Office of the Chief Medical Examiner in Baltimore, MD. She is certified by the American Board of Pathology in Anatomic and Clinical Pathology and in Forensic Pathology.
Before joining HNL Lab Medicine, Dr. Magno was an Assistant Medical Examiner at the State of Maryland Office of the Chief Medical Examiner in Baltimore, MD.
Abir L Mukherjee
MD
Dr. Mukherjee is board certified in Anatomic and Clinical Pathology, with subspecialty board certification in Neuropathology.
As a native of India and a graduate of Calcutta Medical College, Dr. Mukherjee started his career in beautiful Pokhara, Nepal, at the foothills of the Himalayas, teaching medical students and practicing pathology. His interest in research brought him to the Cleveland Clinic, where he was a research fellow for years.
After his residency in Michigan, Dr. Mukherjee completed a fellowship in Neuropathology at The Methodist Hospital/MD Anderson Cancer Center in Houston in 2010. This was followed by a move to Temple University Hospital in Philadelphia, where he practiced Neuropathology and general surgical pathology from 2010-2018. Dr. Mukherjee comes to HNL Lab Medicine from Henry Ford Hospital in Michigan, where he has been the section Chief of Neuropathology since 2018.
Dr. Mukherjee and his family reside in suburban Philadelphia. He and his wife are avid travelers, foodies, and music lovers.
Dr. Mukherjee loves sitar music and plays the instrument himself. Both his wife and son work at the University of Pennsylvania.
Nupam A. Patel
Hematopathologist and Molecular Genetic Pathologist
MD
Christopher Sebastiano
Pathologist
MD
Dr. Sebastiano received his MD from Temple University School of Medicine in Philadelphia. He completed anatomic and clinical pathology residency at New York University School of Medicine in New York, where he served as chief resident. He completed fellowship training in oncologic and breast pathology and cytopathology at Memorial Sloan Kettering Cancer Center in New York. He is certified by the American Board of Pathology in Anatomic and Clinical Pathology, as well as Cytopathology. Prior to joining Health Network Laboratories, he was an assistant professor of pathology at Thomas Jefferson University Hospital in Philadelphia.
Carolina Sforza-Huffman
Pathologist
MD
She is certified by the American Board of Pathology in Anatomic and Cytopathology. Dr. Sforza-Huffman is member of six societies including College of American Pathologists (CAP) and American Society of Clinical Pathologists (ASCP).
Hina Sheikh
Co-Chief, Section of Dermatopathology
MD
Publications
Multifocal CNS infiltration of chronic lymphocytic leukemia in the form of small-cell solid metastatic lesions.Imitola J, Pitt K, Peoples JL, Krynska B, Sheikh H, Kesari S, Azizi SA. J Neurooncol. 2012 Aug;109(1):213-5. doi: 10.1007/s11060-012-0869-5. Epub 2012 May 10. No abstract available. PMID: 22573347
NM-23 gene loss of heterozygosity and protein expression in high-stage laryngeal squamous cell carcinomas.
Sheikh H, Murphy J, Hunt JL. Diagn Mol Pathol. 2006 Mar;15(1):1-6. PMID: 16531762
A 42-year-old woman with a 7-month history of abdominal pain. A, endometriosis involving ileocecal junction and 2 pericolonic lymph nodes; B, intranodal benign glandular inclusions.
Sheikh HA, Krishnamurti U, Bhat Y, Rajendiran S. Arch Pathol Lab Med. 2005 Dec;129(12):e218-21. No abstract available. PMID: 16329741
Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases.
Sheikh HA, Sasatomi E, Finkelstein S, Yousem SA. Am J Surg Pathol. 2005 Oct;29(10):1267-73. PMID: 16160467
Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant.
Fung MK, Sheikh H, Eghtesad B, Lopez-Plaza I. Transfusion. 2004 Nov;44(11):1635-9. PMID: 15504170
p63 expression in assessment of bronchioloalveolar proliferations of the lung.
Sheikh HA, Fuhrer K, Cieply K, Yousem S. Mod Pathol. 2004 Sep;17(9):1134-40. PMID: 15205681 Free Article
Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence.
Sheikh HA, Tometsko M, Niehouse L, Aldeeb D, Swalsky P, Finkelstein S, Barnes EL, Hunt JL. Am J Surg Pathol. 2004 Jan;28(1):101-6. PMID: 14707871 Related citations
Rameen Starling-Roney
Medical and Forensic Pathologist
MD
Publications
Polymorphisms in the taste receptor gene (Tas1r3) region are associated with saccharin preference in 30 mouse strains.Reed DR, Li S, Li X, Huang L, Tordoff MG, Starling-Roney R, Taniguchi K, West DB, Ohmen JD, Beauchamp GK, Bachmanov AA. J Neurosci. 2004 Jan 28;24(4):938-46. PMID:14749438 Free PMC Article
Gary A. Stopyra
Chief, Section of Endocrine Pathology
MD, FCAP, FASCP
Publications
Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib
Christine Saraceni, DO,* P. Mark Li, MD,* Justin F. Gainor, MD, † Gary A. Stopyra, MD,* and Eliot L. Friedman, MD* Journal of Thoracic Oncology®: July 2015 - Volume 10 - Issue 7 - p 1116–1117
Biologically enhanced healing of the human rotator cuff: 8-month postoperative histological evaluation.
Protzman NM, Stopyra GA, Hoffman JK. Orthopedics. 2013 Jan;36(1):38-41. doi: 10.3928/01477447-20121217-06. PMID: 23276334 [PubMed - in process]
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
Isidro AM, Amorosa V, Stopyra GA, Rutenberg HL, Pentz WH, Bridges CR. J Thorac Cardiovasc Surg. 2006 May;131(5):1181-3. Review. No abstract available. PMID: 16678614
Recurrence and bleeding in hibernomas.
Ogilvie CM, Torbert JT, Hosalkar HS, Stopyra GA, Lackman RD. Clin Orthop Relat Res. 2005 Sep;438:137-43. PMID: 16131882
Thigh mass in a 73-year-old woman.
Deirmengian GK, Hosalkar HS, Dolinskas CA ,Stopyra GA, Ogilvie CM, Lackman RD. Clin Orthop Relat Res. 2005 Jan;(430):266-71. No abstract available. PMID: 15662334
47,XXY with associated bilateral renal agenesis.
Barroeta JE, Stopyra GA. Arch Pathol Lab Med. 2004 Mar;128(3):e44-5. PMID: 14987134
Enophthalmos as initial manifestation of occult, mammogram-negative carcinoma of the breast.
Shields CL, Stopyra GA, Marr BP, Moster ML, Shields JA. Ophthalmic Surg Lasers Imaging. 2004 Jan-Feb;35(1):56-7. PMID: 14750765
Desmoplastic small round cell tumor of the lung.
Stopyra GA. Arch Pathol Lab Med. 2003 Jul;127(7):782. No abstract available. PMID: 12823031
Bilateral orbital myeloid sarcoma as initial sign of acute myeloid leukemia: case report and review of the literature.
Shields JA, Stopyra GA, Marr BP, Shields CL, Pan W, Eagle RC Jr, Bernstein J. Arch Ophthalmol. 2003 Jan;121(1):138-42. Review. No abstract available. PMID: 12523908
Utility of CK7 and CK20 immunohistochemistry in the detection of synchronous breast and colon carcinoma in a pleural effusion: a case report and supporting survey of archival material.
Stopyra GA, Warhol MJ, Multhaupt HA. Diagn Cytopathol. 2001 Jul;25(1):54-8. PMID:11466814
Cytokeratin 20 immunoreactivity in renal oncocytomas.
Stopyra GA, Warhol MJ, Multhaupt HA. J Histochem Cytochem. 2001 Jul;49(7):919-20. PMID:11410616
Plasmacytoma with aberrant expression of myeloid markers, T-cell markers, and cytokeratin.
Shin JS, Stopyra GA, Warhol MJ, Multhaupt HA. J Histochem Cytochem. 2001 Jun;49(6):791-2. PMID:11373326
Epstein-Barr virus-associated adult respiratory distress syndrome in a patient with AIDS: a case report and review.
Stopyra GA, Multhaupt HA, Alexa L, Husson M, Stern J, Warhol MJ. Mod Pathol. 1999 Oct;12(10):984-9. PMID:10530565
John Tinsley
Pathologist
MD
Ashley Vogel
Pathologist
MD, DO
Dr. Ashley Vogel is certified by the American Board of Pathology in Anatomic and Clinical Pathology and Hematopathology. She received a Master’s degree in Biotechnology from the University of Pennsylvania School of Engineering and Applied Sciences before attending medical school at Lake Erie College of Osteopathic Medicine.
She completed her combined Anatomic/Clinical Pathology residency, where she served as chief resident, as well as Hematopathology fellowship at Thomas Jefferson University Hospitals in Philadelphia, PA. Dr. Vogel is a member of the United States and Canadian Academy of Pathology (USCAP) and Society for Hematopathology (SH).
She has been active in teaching medical students and resident/fellow physicians and has published and presented in the field of hematopathology.
Kathrine O'Brien
Chairman
MBA
Ms. O’Brien earned a bachelor’s degree at Boston College and a master’s degree in business administration at Columbia University. She has been responsible for building brand equity and executing brand activation plans for Dove, the leading personal wash brand in the U.S. She has led programs that helped Dove achieve its goal of reaching twenty million girls with self-esteem programming. She has been honored as the Cosmetic Executive Woman Achiever.
Ms. O’Brien also serves on the boards of directors at Lehigh Valley Health Network, Tabula Rasa Healthcare, Cosmetic Executive Women and AMAG Pharmaceuticals.
Martin K. Till
President and Chief Executive Officer (CEO) of HNL Lab Medicine (HNL)
Previously he served as CEO of Adept Group/Adept Packaging, the largest packaging consultancy and staffing company in the United States and Europe. Mr. Till served as President and remains a shareholder of Virtual Graphics, LLC, a leading technology company in the direct thermal material business, and was Regional President of J.G. Petrucci Company, Inc., a real estate development and design/build company in the region.
From 1998-2012, Mr. Till was Chief Executive Officer, President and Publisher of The Express-Times and lehighvalleylive.com. Also serving as President of Penn Jersey Advance, the parent company to The Express-Times from 2004-2012, overseeing six daily newspapers, 26 weekly publications and regional websites throughout eastern Pennsylvania and New Jersey.
He earned a bachelor’s degree in business administration from North American University. Mr. Till was a non-commissioned officer in the U.S. Army.
In 2005, Mr. Till was a founding Board member of Team Capital Bank (now Provident Bank).
He serves on the boards for:
Lehigh Valley Health Network (co-Chair)
Health Network Laboratories (Chair)
The Lehigh Valley Partnership
Mr. Till previously served on the Boards of Lafayette Ambassador Bank (Fulton Bank), The Pennsylvania Society, United Way of the Lehigh Valley, and the Pennsylvania News Media Association.
Mr. Till lives in Coopersburg with his wife, Tiffany, and has two children.
Thomas Marchozzi
MBA, CPA
Mr. Marchozzi earned a bachelor’s degree in business administration at Villanova University and a master’s degree in business administration at Drexel University. He has been Senior Vice President and Chief Financial Officer at Universal Health Services, Inc., and Executive Vice President and Chief Financial Officer at Hartford Healthcare.
Jordan Olson
Chair of Pathology at LVHN and Medical Director of HNL Lab Medicine
MD
Michael Pasquale
MD
Dr. Pasquale is a graduate of Bethany College where he received a Bachelor of Science degree in Chemistry. He received his medical degree from Georgetown University School of Medicine. Dr. Pasquale completed his internship and General Surgery residency at Georgetown University Hospital and then completed a Surgical Critical Care Fellowship at the University of Minnesota Hospital and Clinics.
Dr. Pasquale is certified by the American Board of Surgery in General Surgery and Surgical Critical Care. In addition, Dr. Pasquale is a member of the American College of Surgeons Committee on Trauma where he has served on the Executive Committee and as Chief of Region III, the American Association for the Surgery of Trauma where he served on the Outcomes Committee, the Pennsylvania Committee on Trauma where he chaired the Ad Hoc Committee on Site Survey Outcomes Measurements, and the Eastern Association for the Surgery of Trauma where he served as President and a member of the EAST Foundation Board. His research interests are evidence-based outcomes measurement and the development of evidence-based guidelines.
John M. Pierro
MBA
John Pierro is Executive Vice President and Chief Operating Officer of Lehigh Valley Health Network (LVHN), a position he has held since 2021. He oversees operations at the health network’s hospitals and ambulatory locations, and leads the facilities and construction team. Mr. Pierro leads the development of and is responsible for carrying out health network goals, objectives, plans and policies, and ensures LVHN services are delivered in accordance with quality and financial standards. He drives programs and activities to promote a positive environment of professionalism, and works to engage colleagues and build talent to meet the needs of the health network and community.
A results-focused health care executive, Mr. Pierro has leveraged outstanding relationship-based leadership, a passion for excellence in quality outcomes, hospital operating performance, business competencies, innovation and interpersonal attributes to lead award-winning health systems, academic medical centers and community hospitals. He is the only non-physician to receive the Vision and Partnership Award, presented by a group of 60 independent community physicians
During his 25-year career, Mr. Pierro served in the Cabinet of two New Jersey Governors, achieved Leapfrog No. 1 ranking in patient experience and national recognition for Leapfrog “Top 50 and Top 100 Hospitals,” completed more than $2 billion in design and construction projects, acquired and integrated three community hospitals, led market growth, the recruitment of more than 500 new primary care providers, specialists and surgeons, and expanded ambulatory services by opening more than 100 new physician practices and urgent care centers in locations that give patients convenient access to services and a seamless experience across the health system.
Mr. Pierro is a graduate of Bloomsburg University where he earned a Bachelor of Science in Economics and Finance. He studied Health Care and Population Health at Princeton University/Woodrow Wilson School and earned his MBA at The John Hopkins University.
Mr. Pierro and his family are passionate about volunteering in the community. They have supported food pantries, homeless outreach, the improvement of housing and recreation, and hospital events focused on underprivileged children, homelessness and victims of substance abuse.